• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. AstraZeneca Gets FDA Approval for Ovarian Cancer Drug

    AstraZeneca Gets FDA Approval for Ovarian Cancer Drug

  2. AstraZeneca Gets FDA Approval for Ovarian Cancer Drug

    AstraZeneca Gets FDA Approval for Ovarian Cancer Drug

  3. AstraZeneca's Lynparza Approved in EU for Ovarian Cancer Patients

    AstraZeneca's Lynparza Approved in EU for Ovarian Cancer Patients

  4. US Court Finds in Favor of AstraZeneca in Nexium Patent Dispute

    US Court Finds in Favor of AstraZeneca in Nexium Patent Dispute

  5. AstraZeneca Gets European Union Approval For Moventig Drug

    AstraZeneca Gets European Union Approval For Moventig Drug

  6. AstraZeneca , oil shares contribute to FTSE 100's advance

    AstraZeneca , oil shares contribute to FTSE 100's advance

  7. LONDON MARKETS: AstraZeneca , Oil Shares Contribute To FTSE 100's Advance

    LONDON MARKETS: AstraZeneca , Oil Shares Contribute To FTSE 100's Advance

  8. Eli Lilly, AstraZeneca launch patient trial for Alzheimer's treatment

    Eli Lilly, AstraZeneca launch patient trial for Alzheimer's treatment

  9. AstraZeneca New Drug Application For IRESSA Accepted By US FDA

    AstraZeneca New Drug Application For IRESSA Accepted By US FDA

  10. Drug makers face another $65 billion patent cliff

    Drug makers face another $65 billion patent cliff

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.